S
Savara Inc.
SVRA · NASDAQ · Healthcare · 1.1B
Price · close
$5.59
+1.82% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
6.1×
Enterprise value / EBITDAEV/EBITDA
-10.5×
Free cash flow yieldFCF yield
-8.1%
Return on equityROE
-58.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.